GeneSys Biologics Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • GeneSys Biologics's estimated annual revenue is currently $20.5M per year.(i)
  • GeneSys Biologics's estimated revenue per employee is $114,302

Employee Data

  • GeneSys Biologics has 179 Employees.(i)
  • GeneSys Biologics grew their employee count by -17% last year.

GeneSys Biologics's People

NameTitleEmail/Phone
1
Head Quality Control, Biologics - General ManagerReveal Email/Phone
2
Assistant General Manager (Head-Analytical Development and Characterisation)Reveal Email/Phone
3
Senior ManagerReveal Email/Phone
4
Deputy General Manager and Head RND- Drug Substance & MSATReveal Email/Phone
5
Deputy Manager -Manufacturing QMSReveal Email/Phone
6
Quality Control ManagerReveal Email/Phone
7
Deputy General ManagerReveal Email/Phone
8
General ManagerReveal Email/Phone
9
Assistant ManagerReveal Email/Phone
10
ExecutiveReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$12M122-4%N/AN/A
#2
$17.3M22318%N/AN/A
#3
$11.1M14334%N/AN/A
#4
$8.2M14364%N/AN/A
#5
$9.5M12120%N/AN/A
#6
$21.2M24610%N/AN/A
#7
$12M1558%N/AN/A
#8
$18.9M24824%N/AN/A
#9
$12.5M16323%N/AN/A
#10
$20.5M179-17%N/AN/A
Add Company

What Is GeneSys Biologics?

GeneSys Biologics was established in Nov 2014 by a group of like-minded individuals with strong global experience in development of biosimilars. A science-based biosimilar company with the vision of becoming one of the leading global biopharmaceutical companies in the world. GeneSys aims to expand market access across the globe by providing affordable and high quality biosimilars.

keywords:N/A

N/A

Total Funding

179

Number of Employees

$20.5M

Revenue (est)

-17%

Employee Growth %

N/A

Valuation

N/A

Accelerator

GeneSys Biologics News

2022-03-22 - Insulin has been around for 100 years, so why is it still so ...

... with GeneSys Biologics to develop and commercialize three biosimilar versions of insulins in the U.S.—glargine, lispro and aspart.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$14.4M1806%N/A
#2
N/A18229%N/A
#3
$27.2M1833%N/A
#4
$41.9M1836%N/A
#5
$4.8M184124%N/A